`
`CERTIFICATE OF CORRECTION
`
`PATENT NO.
`APPLICATION NO.
`
`: 10,624,564 B1
`: 16/725292
`
`DATED
`INVENTOR(S)
`
`: April 21, 2020
`: Jeroen Poeze
`
`Page 1 of 1
`
`It is certified that error appears in the above-identified patent and that said Letters Patent is hereby corrected as shown below:
`
`On the Title Page
`
`Item (63), Page 2, Column 1 at Lines 21-22, Related US. Application Data, Change “and a
`
`continuation-in—part” to ——Which is a continuation-in—part——.
`
`Item (63), Page 2, Column 1 at Lines 22—23, Related US. Application Data, Change “Aug. 25, 2009,”
`
`to ——“Aug. 25, 2008,--.
`
`In the Specification
`
`In Column 38 at Line 34, Change “15008” to --1500B--.
`
`Signed and Sealed this
`
`Second Day of June, 2020
`
`$4an
`
`Andrei Iancu
`Director offhe United States Patent and Trademark Ofice
`
`1
`
`APPLE 1002
`
`1
`
`APPLE 1002
`
`
`
`Docket N0.: MASCER.002C17
`
`Page 1 of 1
`
`REQUEST FOR CERTIFICATE OF CORRECTION
`
`First Inventor
`
`App. No.
`
`Filed
`
`Patent No.
`
`Issue Date
`
`Title
`
`Conf. No.
`
`:
`
`:
`
`:
`
`:
`
`:
`
`:
`
`:
`
`J eroen Poeze
`
`16/725292
`
`December 23, 2019
`
`106245 64
`
`April 21, 2020
`
`MULTI—STREAM DATA COLLECTION SYSTEM FOR
`NONINVASIVE MEASUREMENT OF BLOOD CONSTITUENTS
`
`5451
`
`
`
`Commissioner for Patents
`
`Office of Data Management
`Attention: Certificates of Correction Branch
`PO. Box 1450
`
`Alexandria, VA 22313-1450
`
`Dear Commissioner:
`
`Enclosed for filing is a Certificate of Correction in connection with the above-identified
`
`patent.
`
`Errors cited in the Certificate of Correction appear to have been incurred through the fault
`of the PTO (see 35 USC § 254, 37 CFR § 1.322, and MPEP § 1480). No fee is believed to be
`
`required. Charge to our Deposit Account No. 11-1410 is authorized for any additional or
`remaining fees.
`
`Respectfully submitted,
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`
`Byz/Scott Cromar/
`Scott A. Cromar
`
`Registration No. 65,066
`Registered Practitioner
`(949) 760-0404
`
`Dated: May 1, 2020
`
`32750664
`
`2
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`CERTIFICATE OF CORRECTION
`
`PATENT NO.
`
`: 10,624,564
`
`APPLICATION NO.
`
`: 16/725292
`
`ISSUE DATE
`
`: April 21 , 2020
`
`INVENTOR(S)
`
`: Jcrocn Poczc
`
`Page 1 of1
`
`It is certified that an error appears or errors appear in the above-identified patent and that said Letters
`
`Patent is hereby corrected as shown below:
`
`On the Title Page
`
`Item (63), Page 2, Column l
`
`at Lines 21—22, Related US. Application Data, Change “and a
`
`continuation-in-part” to --which is a continuation-in-part--.
`
`Item (63), Page 2, Column 1 at Lines 22-23, Related US. Application Data, Change “Aug. 25, 2009,” to
`
`--“Aug. 25, 2008,--.
`
`In the Specification
`
`In Column 38 at Line 34, Change “15008” to ——lSOOB——.
`
`
`
`32750545
`
`MAILING ADDRESS OF SENDER:
`
`Scott A. Cromar
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 Main Street, 14th Floor
`Irvine, California 92614
`
`PTO/SB/44 Equivalent
`
`DOCKET NO. MASCER.002C17
`
`3
`
`
`
`Electronic Acknowledgement Receipt
`
`“—
`
`——
`
`T'tle °f '"Venmm
`
`MULTI—STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD CONSTITUENTS
`
`
`
`First Named Inventor/Applicant Name:
`
`Jeroen Poeze
`
`Customer Number:
`
`64735
`
`Scott Cromar/Wendi Manzanares
`
`Filer Authorized By:
`
`Scott Cromar
`
`Attorney Docket Number:
`
`MASCER.002C17
`
`Receipt Date:
`
`Filing Date:
`
`01—MAY—2020
`
`23—DEC—201 9
`
`Time Stamp:
`
`18:08:50
`
`
`
`Application Type: Utility under 35 USC 111(a)
`
`Payment information:
`
`Submitted with Payment
`
`bbUd
`
`Document
`Number
`
`Document Descri
`
`tion
`
`p
`
`File SizelBytes)I
`Message Digest
`
`Pages
`Multi
`Part I.zip (if appl.)
`
`Request for Certificate of Correction
`
`CoC_C17.pdf
`
`183287649l4b96b7dddd l5c735l725833e81
`
`4
`
`
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`the application.
`
`New Applications Under 35 U.S.C. 111
`lfa new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)—(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DOIEOI903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`New International Application Filed with the USPTO as a Receiving Office
`lfa new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCTIROI1 05) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`
`5
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
` APPLICATION NUMBER FILING OR 371(C) DATE FIRST NAVED APPLICANT ATTY. DOCKET NOJTITLE
`
`
`
`UVTTET‘I STATES DEPARTVIEVT 0F COM—MERGE
`United States Patent and Trademark Office
`Addl'ESS. COMMTSSTOWR FOR PATENTS
`P O Box 1450
`Alexandtia, Yngnia 22313-1450
`www.uspto.gov
`
`
`16/725,292
`12/23/2019
`.Ierocn Poeze
`MASCER.002C17
`CONFIRMATION NO. 5451
`PUBLICATION NOTICE
`
`64735
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`MASIMO CORPORAW (MAW
`2040 MAIN STREET
`FOURTEENTH FLOOR
`IRVINE, CA 92614
`
`I|||I|||||||||||||||||IIILIIIIIIIIIILIIIIIIIIIIIIIIIII|||||I|I|||||||||||I|||
`
`Title:MULT|—STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`CONSTITUENTS
`
`Publication No.US-2020-0129096-A1
`Publication Date:04/30/2020
`
`NOTICE OF PUBLICATION OF APPLICATION
`
`The above-identified application will be electronically published as a patent application publication pursuant to 37
`CFR 1.211, et seq. The patent application publication number and publication date are set forth above.
`
`The publication may be accessed through the USPTO‘s publically available Searchable Databases via the
`Internet at www.uspto.gov. The direct link to access the publication is currently http://www.uspto.gov/patft/.
`
`The publication process established by the Office does not provide for mailing a copy of the publication to
`applicant. A copy of the publication may be obtained from the Office upon payment of the appropriate fee set
`forth in 37 CFR 1.19(a)(1). Orders for copies of patent application publications are handled by the USPTO's
`Public Records Division. The Public Records Division can be reached by telephone at (571) 272-3150 or (800)
`972-6382, by facsimile at (571) 273-3250, by mail addressed to the United States Patent and Trademark Office,
`Public Records Division, Alexandria, VA 22313-1450 or via the Internet.
`
`In addition, information on the status of the application, including the mailing date of Office actions and
`the dates of receipt of correspondence filed in the Office, may also be accessed via the Internet through
`the Patent Electronic Business Center at www.uspto.gov using the public side of the Patent Application
`Information and Retrieval (PAIR) system. The direct link to access this status information is currently
`https://portal.uspto.gov/pair/PublicPair. Prior to publication, such status information is confidential and may only
`be obtained by applicant using the private side of PAIR.
`
`Further assistance in electronically accessing the publication, or about PAIR, is available by calling the Patent
`Electronic Business Center at 1-866-217-9197.
`
`
`
`Office of Data Managment, Application Assistance Unit (571) 272—4000, or (571) 272—4200, or 1—888—786—0101
`
`page 1 of 1
`
`6
`
`
`
`INFORMATION DISCLOSURE
`
`Application No.
`16/725292
`
`Filing Date
`December 23, 2019
`
`PTO/SB/OS E uivalent
`
`STATEMENT BY APPLICANT
`
`First Niamed Inventor
`Art Unit
`
`Jernen Poeze
`3791
`
`(Multiple sheets used when necessary)
`Examiner
`Liu, Chu Chuan
`
`SHEET 1 OF 1
`Attorney Docket No.
`MASCER.002C17
`
`Examiner
`Initials
`
`Cite
`No.
`
`Document Number
`Number - Kind Code (if known)
`Example: 1.234567 81
`
`Publication
`Date
`MM-DD-YYYY
`
`Name
`
`U.S. PATENT DOCUMENTS
`
`FOREIGN PATENT DOCUMENTS
`
`Pages, Columns, Lines Where
`Relevant Passages or
`Relevant Figures Appear
`
`
`
`Foreign Patent Document
`Pages, Columns, Lines
`
`
`Examiner Cite
`Country Code—Number—Kind
`Pubgliggtion
`Name
`Where Relevant Passages
`T1
`
`
`MM-DD-YYYY
`or Relevant Figures
`Initials
`No.
`Code
`A ear
`
`
`Examcle: JP 1234567 A1
`
`
`
`
`
`
`
`
`
`
`
`
`
`NON PATENT LITERATURE DOCUMENTS
`
`Examiner Cite
`Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the
`Initials
`No.
`item (book, magazine, journal, serial, symposium, catalog, etc.), date, page(s), volume—issue
`
`numbers , ublisher, cit and/or countr where ublished.
`2020—03—25 First Amended Complaint for (1) Patent Infringement (2) Trade Secret Misappropriation (3)
`Correction of Inventorship and (4) Ownership of Patents and Demand for Jury Trial, and including
`Exhibits 13-24 (Exhibits 1-12 and 25-31 comprise copies of publicly available U.S. patents and U.S.
`patent application publications, and are not included herein for ease of transmission), Masimo
`Corporation and Cercacor Laboratories, Inc. v. Apple Inc., Case No. 8:20-cv-00048, pgs. 1-94, 983-
`
`1043 (total of 156 pages).
`
`1
`
`Examiner Signature
`
`Date Considered
`
`Include copy of this form with next communication to applicant.
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not
`*Examiner:
`in conformance and not considered.
`
`T1 - Place a check mark in this area when an English language Translation is attached.
`
`
`
`7
`
`
`
`
`
`Docket N0.: MASCER.002C17 Page 1 of 3
`
`INFORMATION DISCLOSURE STATEMENT
`AND NOTICE OF CONCURRENT LITIGATION
`
`First Inventor :
`
`Jeroen Poeze
`
`App. No.
`
`:
`
`16/725292
`
`Filed
`
`For
`
`: December 23, 2019
`
`: MULTI—STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD CONSTITUENTS
`
`Examiner
`
`: Liu, Chu Chuan
`
`Art Unit
`
`Conf. No.
`
`:
`
`:
`
`3791
`
`545 1
`
`Commissioner for Patents
`PO. Box 1450
`
`Alexandria, VA 22313—1450
`
`References and Listing
`
`
`
`Pursuant to 37 CFR 1.56, an Information Disclosure Statement listing references is
`
`provided herewith. Copies of any listed foreign and non—patent literature references are being
`
`submitted.
`
`Pursuant
`
`to 37 CFR l.97(g) and (h), Applicant makes no representation that
`
`the
`
`information is considered to be material to patentability. Additionally, inclusion on this list is
`
`not an admission that any of the cited documents are prior art in this application. Further,
`
`Applicant makes no representation regarding the completeness of this list, or that better art does
`
`not exist.
`
`Related Proceedings
`
`Pursuant
`
`to M.P.E.P § 2001.06(c), Applicant provides this notification of related
`
`litigation proceedings. On January 9, 2020, Applicant, Masimo Corporation, and Cercacor
`
`Laboratories, Inc., filed a complaint in the United States Court for the Central District of
`
`California (Case No. 8:20-cv-00048) against Apple Inc.. The complaint alleges infringement of
`
`US. Patent Nos. 10,258,265; 10,258,266; 10,292,628; 10,299,708; 10,376,190; 10,376,191;
`
`10,588,553; 10,588,554; 10,470,695; 6,771,994; 8,457,703; and 10,433,776. At least US. Patent
`
`Nos. 10,258,265; 10,258,266; 10,292,628; 10,299,708; 10,376,190; 10,376,191; and 10,588,553;
`
`8
`
`
`
`Docket N0.: MASCER.OO2C17
`App. N0.: 16/725292
`
`Page 2 of 3
`
`10,588,554 share a common priority claim with the present application. Copies of related
`
`documents in the proceeding are being submitted herewith.
`
`For convenience in reviewing this submission, the following chart is provided showing
`
`the pending applications which share at least one common priority claim with each of the
`
`asserted patents. It should be noted that other family members that share at least one common
`
`priority claim may have issued as well.
`
`
`
`Patent No.
`
`Pending Family Members
`
`10,258,265
`
`10,258,266
`
`10,292,628
`
`10,299,708
`
`10,376,190
`
`10,376,191
`
`10,588,553
`
`10,588,554
`
`10,470,695
`
`6,771,994
`
`8,457,703
`
`
`
`16/449143
`
`16/534956
`
`16/541987
`
`16/725478
`
`16/725292
`
`16/829510
`
`16/829578
`
`16/829536
`
`16/834467
`
`16/834538
`
`16/532061
`
`16/532065
`
`16/791955
`
`16/791963
`
`15/820082
`
`
`
`
`
`16/834533
`
`
`16/174130
`10,433,776
`
`
`N0 Disclaimers
`
`To thc cxtcnt
`
`that anything in thc Information Disclosure Statcmcnt or thc listcd
`
`references could be construed as a disclaimer of any subject matter supported by the present
`
`application, Applicant hereby rescinds and retracts such disclaimer.
`
`-2-
`
`9
`
`
`
`Docket N0.: MASCER.002C17
`App. N0.: 16/725292
`
`Timing of Disclosure
`
`Page 3 of 3
`
`This Information Disclosure Statement is being filed after the mailing date of a final
`
`action or after the mailing date of a Notice of Allowance.
`
`Respectfully submitted,
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`
`Dated: April 7, 2020
`
`325 84740
`
`By: /Scott Cromar/
`Scott A. Cromar
`
`Registration No. 65,066
`Registered Practitioner
`(949) 760-0404
`
`10
`
`10
`
`
`
`Electronic Acknowledgement Receipt
`
`“—
`
`——
`
`T'tle °f '"Venmm
`
`MULTI—STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD CONSTITUENTS
`
`
`
`First Named Inventor/Applicant Name:
`
`Jeroen Poeze
`
`Customer Number:
`
`64735
`
`Scott Cromar/Frances Tsai
`
`Filer Authorized By:
`
`Scott Cromar
`
`Attorney Docket Number:
`
`MASCER.002C17
`
`Receipt Date:
`
`Filing Date:
`
`07—APR—2020
`
`23—DEC—201 9
`
`Time Stamp:
`
`15:46:16
`
`
`
`Application Type: Utility under 35 USC 111(a)
`
`Payment information:
`
`Submitted with Payment
`
`no
`
`
`
`Document
`Number
`
`Document Descri
`
`tion
`
`p
`
`File SizelBytes)I
`Message Digest
`
`Pages
`Multi
`Part I.zip (if appl.)
`
`1
`
`|DS_C1 7.pdf
`
`dd5582e97ub931c58462ble1d0lb28751d9
`28534
`
`11
`
`11
`
`
`
`Multipart Description/PDF files in .zip description
`
`Document Description
`
`Information Disclosure Statement (IDS) Form (5808)
`
`Transmittal Letter
`
`Warnings:
`Information:
`2095391
`
`Non Patent Literature
`
`
`
`the application.
`
`2020—03—25_First—Amended—
`Complaint—w—Claim—Chart—
`Exh i bits, pdf
`
`3545
`04n9r3464b5264037gaccndieI7f514|b742
`
`Warnings:
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`lfa new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)—(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DOIEOI903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`New International Application Filed with the USPTO as a Receiving Office
`lfa new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/ROI105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`
`12
`
`12
`
`
`
`
`
`UNITED STATES PATENT AND TRADEIWARK OFFICE
`
`UNITED STATES DEPARTMENT OF COIWIVEERCE
`United States Patent and Trademark Office
`Address: COMIVIISSIONER FOR PATENTS
`PO Box 1450
`Alexandria, Virginia 22313-1450
`\vww.uspto gov
`
`APPIICATION NO
`ISSUE DATE
`PATENT NO
`ATTORNEY DOCKET NO.
`CONFIRMATION NO.
`
`16/725,210624564
`MASCER002C17
`5451
`
`64735
`
`7590
`
`04/01/2020
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`MASIMO CORPORATION (MASIMO)
`2040 MAIN STREET
`FOURTEENTH FLOOR
`IRVINE, CA 92614
`
`ISSUE NOTIFICATION
`
`The projected patent number and issue date are specified above.
`
`Determination of Patent Term Adjustment under 35 U SC. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is 0 day(s). Any patent to issue from the above-identified application will include
`an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above-identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Retrieval (PAIR) WEB site (http://pair.uspto. gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office
`of Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee payments
`should be directed to the Application Assistance Unit (AAU) of the Office of Data Management (ODM) at
`(571)-272-4200.
`
`APPLICANT( S)
`
`(Please see PAIR WEB site http://pair.uspto. gov for additional applicants):
`
`Masiino Corporation, Irvine, CA;
`Jeroen Poeze, Rancho Santa Margarita, CA;
`Marcelo Lamego, Cupertino, CA;
`Sean Merritt, Lake Forest, CA;
`Cristiano Dalvi, Lake Forest, CA;
`Hung Vo, Fountain Vallcy, CA;
`Johannes Bruinsma, Opeinde, NETHERLANDS;
`Ferdyan Lesmana, Irvine, CA;
`Massi Joe E. Kiani, Laguna Niguel, CA;
`Greg Olsen, Lake Forest, CA;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`works to encourage and facilitate business investment. To learn more about why the USA is the best country in
`the world to develop technology, manufacture products, and grow your business, visit SelectUSA.gov.
`IR103 (Rev, 10/09)
`
`13
`
`13
`
`
`
`Application N0.:
`Filing Date:
`
`16/725292
`
`December 23, 2019
`
`Docket No.
`
`Patent No.
`
`Title
`MULTI-STREAM SENSOR FOR
`
`Issued
`
`MASCER.004A
`
`MASCER.004C1
`
`8,203,704
`Merritt, et a1,
`8,
`0,503
`0 et al.
`
`NONINVASIVE MEASUREMENT OF
`BLOOD CONSTITUENTS
`HEAT SINK FOR NONINVASIVE MEDICAL
`SENSOR
`MULTI-STREAM EMITTER FOR
`
`06/ 19/2012
`
`10/29/2013
`
`CERCA.005A
`
`MASCER.006A
`
`MASCER.006C1
`
`
`
`MASCER.007C1
`
`9,591,975
`Dal“: 6* 8‘—
`
`MASCER.008A
`
`8,688,183
`
`MASCER.008C1
`
`9,186,102
`
`MASCER.008C2
`
`9,668,680
`
`NONINVASIVE MEASUREMENT OF
`8,515,509
`Bruinsma, 6t 21. BLOOD CONSTITUENTS
`“577,431
`NOISE SHIELDING FOR A NONINVASIVE
`ame_o Ct 31. DEVICE
`9,717,425
`EESESHIELDING FOR A NONINVASIVE
`L ram, et a .
`,
`CONTOURED PROTRUSION FOR
`,
`IMPROVING SPECTROSCOPIC
`05/07/2013
`MEASUREMENT OF BLOOD
`8,437,825
`MASCER.007A
`
`Dal“, 6* 81
`CONSTITUENTS
`CONTOURED PROTRUSION FOR
`IMPROVING SPECTROSCOPIC
`MEASL REMENT OF BLOOD
`CONSTITUENTS
`EMITTER DRIVER FOR NONINVASIVE
`PATIENT MONITOR
`Eminma’ at 31.
`EMITTER DRIVER FOR NONINVASIVE
`PATlEhT MONITOR
`bruinsma, et a}.
`EMITTER DRIVER FOR NONINVASIVE
`PATIENT MONITOR
`bruinsma, fit a}.
`
`08/20/2013
`
`11/05/2013
`
`08/01/2017
`
`03/14/2017
`
`04/01/2014
`
`11/17/2015
`
`06/06/2017
`
`
`
`
`
`08/07/2019
` 16/534956
`
`
`
`MASCER.009DA D621516
`
`PATIENT MONITORING SENSOR Kiani, et a1.
`
`08/10/2010
`
`MASCER.010DA D606659
`
`PATIENT MONITOR
`
`Kiani, et a1.
`
`12/22/2009
`
`Docket No.
`
`Serial No.
`
`MASCER.002A
`
`12/534827
`
`08/03/2009
`
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`COVSTITUENTS
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`06/21/2019
`16/449143
`MASCER.002C9
`MEASUREMENT OF BLOOD
`
`CONSTITUENTS
`ML LTI—STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`
`MASCER.002C 10
`
`08/07/2019
`
`MASCER.002C1 1
`16
`s
`
`16/534949
`
`to document,
`
`/D.M./
`
`5/17/2020
`
`-3-
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/C.L/
`
`14
`
`14
`
`
`
`Application N0.:
`Filing Date:
`
`16/725292
`December 23, 2019
`
`References for Examiner Consideration
`
`Applicant wishes to draw the Examiner's attention to, and encourages the Examiner to
`
`review,
`
`the following co-owned patents and/or applications and their existing and ongoing
`
`prosecution history, including without limitation Office Actions, Amendments, Remarks, and
`
`any other potentially relevant documents:
`
`
` Docket No. Patent No. Title Issued
`
`
`
`MASCER.002C1
`
`MASCER.002C2
`
`
`
`MASCER.002C3
`Changc(s> a 1;“;
`to aocumen
`/D~M/
`5/1 7/2020
`
`MASCER.OO2C4
`
`9,277,880
`F0616? Ct 3L
`
`10,335,068
`F0926: 6t 31-
`
`10,258,265i
`FCC“? 5*“ 3 ~
`
`t£0,258,266l
`0616’ 6t 8 ‘
`
` F0619 6t 31'
`
`MASCER.002C6
`
`10,292,628
`
`MASCER.002C7
`
`MASCEROOZCS
`
`MASCER.003A
`
`10,376,190
`F0616: ct 31-
`
`10,376,191
`Foeze, et a1.
`
`
`
`
`
`
`
`
`
`03/08/2016
`
`07/02/2019
`
`04/16/2019
`
`04/16/2019
`
`05/21/2019
`
`08/13/2019
`
`08/13/2019
`
`01/14/2014
`
`12/09/2014
`
`
`
`
`
`ML LTI—STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MASCER.002C5
`10,299,708
`MEASUREMENT OF BLOOD
`05/28/2019
`
`F0619 6* 8“
`CONSTITUENTS
`MI LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`ML LTI—STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`ML LTI—STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`ML LTI-STREAM SENSOR FRONT ENDS
`
`FOR NONINVASIVE MEASUREMENT OF
`8,630,691
`Lamego, et a1. BLOOD CONSTITUENTS
`ML LTI-STREAM SENSOR FRONT ENDS
`
`MASCER.003D1
`
`8,909,310
`Lamegq et a1.
`
`FOR NONINVASIVE MEASUREMENT OF
`BLOOD CONSTITUENTS
`
`-2-
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/C.L/
`
`15
`
`15
`
`
`
`2018/021637008/2015-97-1-9-291-9- W.151’iigiiro,et al.
`1239
`h
`2019/0216379
`07-18-2019
`Al-Ali et al.
`i 1240
`i3: ' . ‘ j 5
`
`/D~M
`1241
`2019/0221966
`07—18—2019
`Kiani et al.
`5/} 8
`, e
`1242
`2019/0223804
`07-25-2019
`Blank et al
`
`1243
`2019/0231199
`08—01—2019
`Al—Ali et al.
`
`INFORMATION DISCLOSURE
`
`Application No.
`16/725292
`
`Filing Date
`December 23, 2019
`
`PTO/SB/OS E uivalent
`
`STATEMENT BY APPLICANT
`
`First Named Inventor
`Art Unit
`
`Jernen Poeze
`2688
`
`(Multiple sheets used when necessary)
`
`Examiner
`
`Unassigned
`
`SHEET 45 OF 57
`
`Attorney Docket No.
`
`MASCER.002C17
`
`
`
`
`
`Efigfser
`
`U.S. PATENT DOCUMENTS
`
`Pas:triiiszgtggzztier
`fig? )(
`
`Example: 1,234,567 B1
`MM-DD-YYYY
`Relevant Figures Appear
`2019/0192076
`06-27-2010 McHale et al.
`
`
`1234
`2019/0200941
`07—04—2019
`Chandran et al.
`
`
`
`1233
`
`,
`
`1235
`
`1236
`1237
`
`1238
`
`2019/0201623
`
`2019/0214778
`2019/0209025
`
`2019/0216319
`
`1244
`
`2019/0231241
`
`1246
`1247
`
`1248
`1249
`
`1250
`
`1251
`
`2019/0239787
`2019/0239824
`
`2019/0254578
`2019/0261857
`
`2019/0269370
`
`2019/0274627
`
`1253
`
`2019/0290136
`
`
`
`
`
`
`1245
`2019/0231270
`08—01—2019
`Abdul-Hafiz et al.
`
`
`
`07-04-2019
`
`07-11-2019
`07-11-2019
`
`07-18-2019
`
`Kiani
`
`Scruggs et al.
`Al-Ali
`
`Poeze et al.
`
`08-01-2019
`
`Al-Ali et al.
`
`Pauley et al.
`08-08-2019
`08-08-2019 Muhsin et al.
`
`08-22-2019
`08-29-2019
`
`09-05-2019
`
`09-12-2019
`
`Lamego
`Al-Ali
`
`Al-Ali et al.
`
`Al-Ali et al.
`
`09-26-2019
`
`Dalvi et al.
`
`
`
`
`
`
`1252
`2019/0274635
`09—12—2019
`Al—Ali et al.
`
`
`1254
`2019/0298270
`10—03—201 9
`Al—Ali et al.
`
`1255
`2019/0304601
`10-03-2019
`Sampath et al.
`
`1256
`2019/0304605
`10—03—201 9
`AI—Ali
`
`1257
`
`1258
`
`1259
`
`1260
`
`2019/0307377
`
`2019/0320906
`
`2019/0320959
`
`10-10-2019
`
`Perea et al.
`
`10-24-2019 Olsen
`
`10-24-2019
`
`Al-Ali
`
`2019/0320988
`
`10-24-2019
`
`Ahmed et al.
`
`
`
`Examiner Signature
`
`Date Considered
`
`Include copy of this form with next communication to applicant.
`
`Initial if reference considered. whether or not citation is in conformance with MPEP 609. Draw line through citation if not
`*Examiner:
`in conformance and not considered.
`
`T1 - Place a check mark in this area when an English language Translation is attached.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/C.L/
`
`16
`
`16
`
`
`
`Application N0.:
`Filing Date:
`
`16/725292
`
`December 23, 2019
`
`References for Examiner Consideration
`
`Applicant wishes to draw the Examiner's attention to, and encourages the Examiner to
`
`review,
`
`the following co-owned patents and/or applications and their existing and ongoing
`
`prosecution history, including without limitation Office Actions, Amendments, Remarks, and
`
`any other potentially relevant documents:
`
`
`
`
`
`
`MASCER.002C1
`
`9,277,880
`
`MASCER.002C2
`
`10,335,068
`
`MASCER.002C3
`
`10,258,265
`
`MASCER.002C4
`
`10,25 8,266
`
`MASCER.002C6
`
`10,292,628
`
`MASCER.002C7
`
`10,376,190
`
`MASCER.002C8
`
`10,376,191
`
`MASCER.003A
`
`8,630,691
`
`MASCER.003D1
`
`8,909,310
`
`
`
` VII
`ML
`
`03/08/2016
`
`07/02/2019
`
`04/16/2019
`
` 05/21/2019
`
`Docket No. Issued Patent No. Title
`
`ML
`LTI— STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`ME
`ASUREMENT OF BLOOD
`CONSTITUENTS
`ML
`LTI- STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`ME
`ASUREMENT OF BLOOD
`CONSTITUENTS
`ML
`LTI- STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`ME
`ASUREMENT OF BLOOD
`CONSTITUENTS
`ML
`LTI- STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`VIE
`ASUREMENT OF BLOOD
`CONSTITUENTS
`ML
`LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`05/28/2019
`MASCER.002C5
`10,299,708
`VIE
`ASUREMENT OF BLOOD
`
`CONSTITUENTS
`LTI—STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`ME
`ASUREMENT OF BLOOD
`CONSTITUENTS
`ML
`LTI— STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`ME
`ASUREMENT OF BLOOD
`CONSTITUENTS
`ML
`LTl-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`ME
`ASUREMENT OF BLOOD
`CONSTITUENTS
`LTI- STREAM SENSOR FRONT ENDS
`FOR NONINVASIVE MEASUREMENT OF
`BLOOD CONSTITUENTS
`ML
`LTI- STREAM SENSOR FRONT ENDS
`FOR NONINVASIVE MEASUREMENT OF
`BLOOD CONSTITUENTS
`
`
`
`04/16/2019
`
`08/13/2019
`
`08/13/2019
`
`01/14/2014
`
`12/09/2014
`
`-2-
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/C.L/
`
`17
`
`17
`
`
`
`Application N0.:
`Filing Date:
`
`16/725292
`
`December 23, 2019
`
`Patent No.
`
`Title
`MULTI-STREAM SENSOR FOR
`
`Issued
`
`MASCER.004A
`
`8,203 ,704
`
`NONINVASIVE MEASUREMENT OF
`BLOOD CONSTITUENTS
`
`06/19/2012
`
`MASCER.OO4C1
`
`8,570,503
`
`213508;“ FOR NONINVASIVE MEDICAL
`MULTI-STREAM EMITTER FOR
`
`CERCA005A
`
`8,515,509
`
`NONINVASIVE MEASUREMENT OF
`BLOOD CONSTITUENTS
`
`MASCER.OO6A
`MASCER.OO6C1
`
`8,577,431
`9,717,425
`
`MASCER.007A
`
`8,437,825
`
`MASCER.007C1
`
`9,591,975
`
`MASCERDOSA
`
`8,688,183
`
`MASCER008C1
`
`9,186,102
`
`MASCER008C2
`MASCER.OO9DA
`
`9,668,680
`D621516
`
`EESEEHIELDING FOR A NONINVASIVE
`EESEEHIELDING FOR A NONINVASIVE
`CONTOURED PROTRUSION FOR
`IMPROVING SPECTROSCOPIC
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`CONTOURED PROTRUSION FOR
`IMPROVING SPECTROSCOPIC
`MEASL REMENT OF BLOOD
`CONSTITUENTS
`EMITTER DRIVER FOR NONINVASIVE
`EATlE1\T MONITOR
`EMITTER DRIVER FOR NONINVASIVE
`PATIEM MONITOR
`EMITTER DRIVER FOR NONINVASIVE
`EATlE1\T MONITOR
`PATIENT MONITORING SENSOR
`
`MASCERDIODA
`
`D606659
`
`PATIENT MONITOR
`
`Docket No.
`
`Serial No.
`
`10/29/2013
`
`08/20/2013
`
`11/05/2013
`08/01/2017
`
`,
`05/07/2013
`
`03/14/2017
`
`04/01/2014
`
`11/17/2015
`
`06/06/2017
`08/10/2010
`
`12/22/2009
`
`MASCERDOZA
`
`12/534827
`
`MASCER.002C9
`
`16/449143
`
`
`
`
`
`
`08/07/2019
` 16/534956
`
`
`
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`COVSTITUENTS
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`
`CONSTITUENTS
`ML LTI—STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`
`MASCEROOZC 10
`
`MASCER.002C1 1
`
`16/534949
`
`08/03/2009
`
`06/21/2019
`
`08/07/2019
`
`-3-
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/C.L/
`
`18
`
`18
`
`
`
`Application N0.:
`Filing Date:
`
`16/725292
`December 23, 2019
`
`MASCER.002C12
`
`16/541987
`
`08/15/2019
`
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`COVSTITUENTS
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`08/19/2019
`16/544713
`MASCER.002C13
`MEASUREMENT OF BLOOD
`
`CONSTITUENTS
`ML LTI—STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`ML LTI-STREAM DATA COLLECTION
`SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD
`CONSTITUENTS
`ML LTI-STREAM SENSOR FOR
`NONINVASIVE MEASUREMENT OF
`BLOOD CONSTITUENTS
`
`
`
`
`
`MASCERDOZC 14
`
`16/544755
`
`MASCERDOZC 15
`
`16/594980
`
`MASCER.002C16
`
`16/725478
`
`MASCER.004C3
`
`14/064055
`
`08/19/2019
`
`10/07/2019
`
`12/23/2019
`
`10/25/2013
`
`MASCER.006C2
`MASCER.011A
`
`15/660743
`12/497506
`
`SEfiEEHIELDING FOR A NONINVASIVE
`$333K FOR NONINVASIVE MEDICAL
`
`07/26/2017
`07/02/2009
`
`Applicant notes that cited references, office actions, responses and notices of allowance
`
`currently exist or will exist with reference to the above—referenced matters. Applicant also
`
`understands that the Examiner has access to sophisticated online Patent Office computing
`
`systems that provide ready access to the full file histories of these matters including, for example,
`
`specifications, drawings, pending claims, cited art, office actions, responses, declarations, and
`
`notices of allowance. Rather than submit copies of these file histories, Applicant respectfully
`
`requests that the Examiner continue to review these file histories online for past, current, and
`
`future information about these matters that may be relevant to examination of the present
`
`application. Also, if the Examiner cannot readily access these file histories, Applicant would be
`-4-
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/C.L/
`
`19
`
`19
`
`
`
`Application N0.:
`Filing Date:
`
`16/725292
`December 23, 2019
`
`pleased to provide any portion of any of the file histories at any time upon specific Examiner
`
`request.
`
`No Disclaimers
`
`To the extent
`
`that anything in the Information Disclosure Statement or the listed
`
`references could be construed as a disclaimer of any subject matter supported by the present
`
`application, Applicant hereby rescinds and retracts such disclaimer.
`
`Timing of Disclosure
`
`This Information Disclosure Statement is being filed within three months of the filing
`
`date or date of national phase entry, and no fee is believed to be required.
`
`The Commissioner is hereby authorized to charge any additional fees which may be
`
`required, or credit any overpayment, to Account No. l 1—1410.
`
`Respectfully submitted,
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`
`
`Dated: December 27 2019
`
`31934708
`
`By: /Scott Cromar/
`Scott A. Cromar
`
`Registration No. 65,066
`Registered Practitioner
`Customer No. 64735
`
`(949) 760-0404
`
`20
`
`20
`
`
`
`IN FORMATION D | SCLOSU RE
`
`Application No.
`16/725292
`
`Filing Date
`December 23. 2019
`
`PTO/SB/OS E uivalent
`
`
`
`
`
`STATEMENT BY APPLICANT
`
`First Named Inventor
`Art Unit
`
`Jernen Pneze
`2688
`
`(Multiple sheets used when necessary)
`
`Examiner
`
`Unassigned
`
`SHEET 1 OF 57
`
`Attorney Docket No.
`
`MASCER.002C17
`
`Pagetaiiszgtggzztier
`fig? ,1
`
`Example: 1,234,567 B1
`MM-DD-YYYY
`Relevant Figures Appear
`3,910,701
`10-07-‘975
`
`Efigfser
`
`1
`
`U.S. PATENT DOCUMENTS
`
`Henderson et al.
`
`
`2
`4,114,604
`09—19—‘ 978
`Shaw et al.
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`4,258,719
`
`4,267,844
`
`4,438,338
`
`4,444,471
`
`4,653,498
`
`4,655,225
`
`03-31-‘ 981
`
`Lewyn
`
`05-19-‘ 981
`
`Yamanishi
`
`03-20-‘ 984
`
`Stitt
`
`04-24-‘ 984
`
`Ford et al.
`
`03-31-‘ 987
`
`New, Jr. et al.
`
`04-07-‘ 987 Dahne et al.
`
`
`9
`4,684,245
`08—04—‘ 987
`Goldring
`
`10
`
`4,709,413
`
`11-24-‘ 987
`
`Forrest
`
`
`11
`4,755,676
`07—05—‘ 988 Gaalema et al.
`
`12
`
`4,781,195
`
`11-01-‘988 Martin
`
`
`13
`4,805,623
`02—21—‘ 989
`Jobsis
`
`14
`
`4,825,872
`
`05-02-‘989
`
`Tan et al.
`
`Jaeb et al.
`
`
`
`
`
`
`
`23
`
`25
`
`26
`
`27
`
`28
`
`5,069,214
`
`5,086,229
`
`5,099,842
`
`5,122,925
`
`5,131,391
`
`
`
`15
`
`16
`
`17
`
`18
`
`19
`
`4,880,304
`
`4,960,128
`
`4,964,408
`
`5,028,787
`
`5,035,243
`
`11-14-‘ 989
`
`10-02-‘ 990
`
`10-23-‘ 990
`
`07-02-‘ 991
`
`07-30-‘991
`
`Gordon et al.
`
`Hink et al.
`
`Rosenthal, et al.
`
`Muz, Edwin
`
`
`24
`5,077,476
`12—31—‘ 991
`Rosenthal
`
`
`
`
`
`
`
`12-03-‘ 991
`
`02-04-‘ 992
`
`Samaras et al.
`
`Rosenthal et al.
`
`03-31-‘ 992 Mannheimer et al.
`
`06-16-‘ 992
`
`Inpyn
`
`07-21-‘ 992
`
`Sakai et al.
`
`
`
`21
`5,043,820
`08-27-‘ 991 Wyles et al.
`
`22
`5,069,213
`12—03—‘ 991
`Polczynski
`
`
`20
`5,041,187
`08—20—‘991
`Hink et al.
`
`Examiner Signature
`
`Date Considered
`
`Include copy of this form with next communication to applicant.
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not
`*Examiner